Online inquiry

IVTScrip™ mRNA-Human ACP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14238MR)

This product GTTS-WK14238MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACP1 protein. This product can be used in Ionocyte cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001040649.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 52
UniProt ID P24666
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14238MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27842MR IVTScrip™ mRNA-Human ATAT1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ATAT1
GTTS-WK25157MR IVTScrip™ mRNA-Human ATG2A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATG2A
GTTS-WK0545MR IVTScrip™ mRNA-Human CD10, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CD10
GTTS-WK9366MR IVTScrip™ mRNA-Human ABHD17A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ABHD17A
GTTS-WK16667MR IVTScrip™ mRNA-Human ANAPC1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANAPC1
GTTS-WK18758MR IVTScrip™ mRNA-Human AMPD2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AMPD2
GTTS-WK10823MR IVTScrip™ mRNA-Human AASS, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA AASS
GTTS-WK4330MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA Carboxypeptidase M
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →